348.18
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $348.18, with a volume of 1.16M.
It is down -0.37% in the last 24 hours and up +12.32% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$349.49
Open:
$347.73
24h Volume:
1.16M
Relative Volume:
0.49
Market Cap:
$78.40B
Revenue:
$189.25B
Net Income/Loss:
$5.35B
P/E Ratio:
14.82
EPS:
23.4948
Net Cash Flow:
$5.34B
1W Performance:
-2.78%
1M Performance:
+12.32%
6M Performance:
-19.97%
1Y Performance:
-29.94%
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ELV
Elevance Health Inc
|
348.18 | 78.92B | 189.25B | 5.35B | 5.34B | 23.49 |
![]()
UNH
Unitedhealth Group Inc
|
356.67 | 325.98B | 422.82B | 22.09B | 25.27B | 23.09 |
![]()
CVS
Cvs Health Corp
|
81.37 | 101.03B | 386.46B | 4.49B | 4.78B | 3.5841 |
![]()
CI
Cigna Group
|
291.07 | 80.65B | 261.22B | 5.40B | 3.94B | 18.31 |
![]()
HUM
Humana Inc
|
267.28 | 31.46B | 123.11B | 1.58B | 2.44B | 13.03 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-14-25 | Initiated | Goldman | Neutral |
Jul-21-25 | Downgrade | Argus | Buy → Hold |
Jul-18-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mar-17-25 | Upgrade | Argus | Hold → Buy |
Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
Oct-18-24 | Downgrade | Argus | Buy → Hold |
Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
Jun-24-24 | Initiated | Morgan Stanley | Overweight |
May-30-24 | Initiated | Robert W. Baird | Outperform |
Mar-06-24 | Initiated | Barclays | Overweight |
Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
How currency fluctuations impact Elevance Health Inc. stock2025 Market Sentiment & Fast Entry High Yield Tips - newser.com
Elevance Health Draws Fresh Capital Inflows, According to Recent Filing - The Motley Fool
Is Elevance Health Inc. stock supported by strong cash flowsJuly 2025 Weekly Recap & Daily Profit Focused Stock Screening - newser.com
What’s next for Elevance Health Inc. stock pricePortfolio Update Summary & Consistent Profit Trading Strategies - newser.com
How Elevance Health Inc. stock reacts to Fed rate cutsTrade Ideas & Daily Stock Momentum Reports - newser.com
How to interpret RSI for Elevance Health Inc. stock2025 Dividend Review & Entry Point Confirmation Signals - newser.com
Bernstein Adjusts Price Target on Elevance Health to $420 From $445, Maintains Outperform Rating - MarketScreener
Wall Street's Insights Into Key Metrics Ahead of Elevance Health (ELV) Q3 Earnings - Yahoo Finance
Analyzing Elevance Health After ACA Subsidy Uncertainty Drives Big Swings in 2025 - Yahoo Finance
Will Rising Costs Hurt Elevance's Q3 Earnings Despite Higher Premiums? - TradingView
Trend analysis for Elevance Health Inc. this weekBear Alert & Real-Time Stock Movement Alerts - newser.com
Evaluating Elevance Health (ELV) Shares After Recent 12% Rally: Is There More Value Ahead? - Yahoo Finance
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit - The Malaysian Reserve
Humana Loses Court Battle Over Medicare Advantage Ratings, Billions In Payments At Risk - Benzinga
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Analyzing recovery setups for Elevance Health Inc. investorsJuly 2025 Highlights & Consistent Growth Equity Picks - newser.com
Is Elevance Health Inc. stock trading at a premium valuationTrade Analysis Report & Daily Oversold Bounce Ideas - newser.com
Applying chart zones and confluence areas to Elevance Health Inc.Market Activity Recap & Precise Swing Trade Entry Alerts - newser.com
Chart based exit strategy for Elevance Health Inc.Portfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Key metrics from Elevance Health Inc.’s quarterly dataJuly 2025 Catalysts & Long-Term Capital Growth Strategies - newser.com
Elevance Health, Inc. $ELV Shares Bought by Verdence Capital Advisors LLC - MarketBeat
Vest Financial LLC Buys 14,809 Shares of Elevance Health, Inc. $ELV - MarketBeat
Pzena Investment Management LLC Acquires 16,296 Shares of Elevance Health, Inc. $ELV - MarketBeat
Real time breakdown of Elevance Health Inc. stock performanceQuarterly Investment Review & Reliable Volume Spike Alerts - newser.com
Lawson Kroeker Investment Management Inc. NE Raises Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
Vanguard Personalized Indexing Management LLC Raises Holdings in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Shares Sold by Drucker Wealth 3.0 LLC - MarketBeat
Stonehage Fleming Financial Services Holdings Ltd Buys Shares of 2,292 Elevance Health, Inc. $ELV - MarketBeat
Lmcg Investments LLC Reduces Holdings in Elevance Health, Inc. $ELV - MarketBeat
Vontobel Holding Ltd. Sells 732 Shares of Elevance Health, Inc. $ELV - MarketBeat
Callan Family Office LLC Has $1.75 Million Stock Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health (NYSE:ELV) Price Target Raised to $370.00 - MarketBeat
Triodos Investment Management BV Has $36.24 Million Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Shares Sold by Aberdeen Group plc - MarketBeat
Ramirez Asset Management Inc. Increases Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
B of A Securities Maintains Elevance Health (ELV) Neutral Recommendation - Nasdaq
Market reaction to Elevance Health Inc.’s recent newsJuly 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Group Health Insurance Market Is Booming Worldwide 2025-2032 | UnitedHealth Group, Anthem (Elevance Health) - InsuranceNewsNet
Elevance Health Q3 EPS Forecast Decreased by Wolfe Research - MarketBeat
When is the best time to exit Elevance Health Inc.2025 Historical Comparison & Growth Oriented Trade Recommendations - newser.com
Elevance Health Reaffirms 2025 Earnings Guidance - MSN
Elevance Health (ELV) Analyst Rating Update: Price Target Raised by Mizuho | ELV Stock News - GuruFocus
What's Driving the Market Sentiment Around Elevance Health Inc? - Sahm
Will Elevance Health Inc. stock outperform global peersJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Elevance Health (NYSE:ELV) Upgraded by Weiss Ratings to Hold (C-) Rating - MarketBeat
Strategies to average down on Elevance Health Inc.Gap Down & Stock Timing and Entry Methods - newser.com
Barclays Maintains Elevance Health (ELV) Overweight Recommendation - Nasdaq
Can Digital Workflows at Optum Rx Transform UNH's Patient Experience? - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elevance Health, Inc. (ELV) And Encourages Shareholders to Connect - ACCESS Newswire
Mizuho Adjusts Price Target on Elevance Health to $420 From $342, Maintains Outperform Rating - MarketScreener
Elevance Health (ELV): Barclays Raises Price Target to $395 | ELV Stock News - GuruFocus
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):